Related Experiment Video
Updated: Aug 18, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Atrial fibrillation and embolic complications
1Department of Internal Medicine, Faculty of Medicine, Addis Ababa University, Ethiopia.
Insights
This study on cardiac patients with atrial fibrillation (AF) found rheumatic heart disease to be a major cause of embolic episodes. Anticoagulation is recommended for high-risk AF patients to prevent systemic emboli.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Atrial fibrillation (AF) is a common cardiac arrhythmia associated with an increased risk of systemic embolization.
- Rheumatic heart disease (RHD) is a significant cause of morbidity and mortality worldwide, particularly in developing countries.
- Understanding the specific risk factors and outcomes of AF in different patient populations is crucial for effective management.
Purpose of the Study:
- To analyze the clinical characteristics and embolic complications in a cohort of cardiac patients with atrial fibrillation (AF).
- To identify the primary causes of embolization in this AF patient group.
- To provide recommendations for anticoagulation therapy to mitigate embolic risk.
Main Methods:
- Retrospective analysis of clinical records from 136 cardiac patients with AF at Black Lion Hospital.
- Data collected included patient demographics, underlying cardiac conditions, and incidence of embolic events.
- Statistical analysis was performed to determine the prevalence of different heart diseases and causes of embolization.
Main Results:
- The study included 136 patients with a mean age of 41 years; females were more prevalent (1.0:1.6 male to female ratio).
- Rheumatic heart disease (RHD) was the predominant underlying condition (66.3%), followed by hypertension (10.3%).
- Embolic episodes occurred in 19.1% of patients, with cerebrovascular accidents (21 cases) and femoral artery occlusion (5 cases) being the main manifestations. Rheumatic valvular heart diseases, especially mitral stenosis, were the leading cause of embolization (65.5%).
Conclusions:
- Rheumatic heart disease is a major risk factor for systemic embolization in patients with atrial fibrillation.
- A significant proportion of AF patients experienced embolic events, highlighting the need for effective preventive strategies.
- Anticoagulation is strongly recommended for AF patients with recent congestive heart failure, prior thromboembolism, or hypertension, provided no contraindications exist.
Abstract:
Clinical records of 136 cardiac patients with atrial fibrillation (AF) followed in the cardiac clinic of the Black Lion Hospital were analysed. The mean age of the patients was 41 +/- 13 years, with a male to female ratio of 1.0:1.6. Rheumatic heart disease (RHD) was found in 66.3%, hypertension in 10.3%, cardiomyopathy in 8.8% and ischaemic heart disease in 6.6%. Embolic episodes occurred in 26 (19.1%) cases with five deaths. Twenty-one patients had cerebrovascular accident while five had femoral artery occlusion. The major cause of embolisation was rheumatic valvular heart diseases (65.5%), especially mitral stenosis. In order to reduce the high risk of systemic emboli, it is recommended that patients with AF and associated recent onset of congestive heart failure, previous history of thromboembolism and hypertension should be anticoagulated if there are no contraindications.
More Related Videos
Related Concept Videos
Dysrhythmias II: Classification of Tachyarrhythmias
Venous Thrombosis I: Introduction
Pulmonary Embolism I: Introduction
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Pulmonary Embolism I: Introduction

